These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16107986)

  • 1. Perspective on HIV infection and aging: emerging research on the horizon.
    Casau NC
    Clin Infect Dis; 2005 Sep; 41(6):855-63. PubMed ID: 16107986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus in an aging population, a complication of success.
    Kirk JB; Goetz MB
    J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection in older patients in the HAART era.
    Grabar S; Weiss L; Costagliola D
    J Antimicrob Chemother; 2006 Jan; 57(1):4-7. PubMed ID: 16284223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy.
    Zhao H; Goetz MB
    J Antimicrob Chemother; 2011 Jun; 66(6):1210-4. PubMed ID: 21421583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and dementia in older adults.
    Valcour V; Paul R
    Clin Infect Dis; 2006 May; 42(10):1449-54. PubMed ID: 16619159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and aging.
    Blanco JR; Caro AM; Pérez-Cachafeiro S; Gutiérrez F; Iribarren JA; González-García J; Ferrando-Martínez S; Navarro G; Moreno S
    AIDS Rev; 2010; 12(4):218-30. PubMed ID: 21179186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV in older adults.
    Simone MJ; Appelbaum J
    Geriatrics; 2008 Dec; 63(12):6-12. PubMed ID: 19061274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection.
    Sabundayo BP; McArthur JH; Langan SJ; Gallant JE; Margolick JB
    Pharmacotherapy; 2006 May; 26(5):674-81. PubMed ID: 16637796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients.
    Fernández Cotarelo MJ; Abellán Martínez J; Guerra Vales JM; Martínez Sánchez P; Rodrigo Gómez De La Bárcena M; Salto Fernández E
    Clin Infect Dis; 2003 Oct; 37(7):973-7. PubMed ID: 13130410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.